Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1726 to 1740 of 7707 results

  1. Cimavax for treating wild-type EGFR-positive non-small-cell lung cancer [1259]

    In development [GID-TA10225] Expected publication date: TBC

    Technology appraisal guidance
    In development

  2. Glatiramer acetate depot for multiple sclerosis [TS ID 10620]

      Status ...

    Technology appraisal guidance
    Topic selection

  3. Emtricitabine/tenofovir alafenamide for human immunodeficiency virus type-1 infection [TS ID 10723]

      Status ...

    Technology appraisal guidance
    Topic selection

  4. Dupilumab for maintenance treatment of uncontrolled moderate to severe asthma in children 6 to 11 years [TS ID 10085]

      Status ...

    Technology appraisal guidance
    Topic selection

  5. Dupilumab for children with severe atopic dermatitis [TS ID 10434]

      Status ...

    Technology appraisal guidance
    Topic selection

  6. Zamtocabtagene autoleucel for treating relapsed or refractory diffuse large B-cell lymphoma after 2 or more therapies TS ID 10765

    Awaiting development [GID-TA11050] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  7. REGN5458 for treating relapsed or refractory multiple myeloma TS ID 10443

    Awaiting development [GID-TA11052] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  8. Dulaglutide for treating type 2 diabetes in children and young people TS ID 10660

      Status ...

    Technology appraisal guidance
    Topic selection

  9. Estetrol for treating vasomotor symptoms associated with the menopause in people aged 40 to 65 ID4037

    Awaiting development [GID-TA11059] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  10. Lumella Pre-Eclampsia Test (MT687)

      Status ...

    Diagnostics guidance
    Topic selection

  11. TUC Safety Valve to prevent balloon inflation in the urethra during transurethral catheterisation (MT512)

      Status ...

    Medical technologies guidance
    Topic selection

  12. Bladder EpiCheck for the detection of bladder cancer recurrence (MT706)

      Status ...

    Diagnostics guidance
    Topic selection

  13. Cenobamate for adjunctive treatment of primary generalised tonic-clonic seizures in epilepsy TS ID 10214

    Awaiting development [GID-TA11069] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  14. Mavorixafor for treating WHIM syndrome ID3946

    Awaiting development [GID-TA10833] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  15. Safe prescribing and withdrawal management of prescribed drugs associated with dependence and withdrawal

    Awaiting development [GID-QS10106] Expected publication date: TBC

    Quality standard
    Awaiting development